A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes

NCT07712562 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Marrow Failure Syndromes
Aplastic Anemias
Severe Aplastic Anemia (SAA)
Severe Aplastic Anemia, Relapse
Severe Aplastic Anemia, Refractory
Non-severe Aplastic Anemia

Interventions

DRUG: Dibotatug (DR-01)

Sponsor

Dren Bio